Establishing common cost measures to evaluate the economic value of patient navigation programs

建立通用的成本衡量指标,以评估患者导航项目的经济价值

阅读:1

Abstract

BACKGROUND: Patient navigation is an intervention aimed at reducing barriers to health care for underserved populations as a means to reduce cancer health disparities. Despite the proliferation of patient navigation programs across the United States, information related to the economic impact and sustainability of these programs is lacking. METHODS: After a review of the relevant literature, the Health Services Research (HSR)-Cost workgroup of the American Cancer Society National Patient Navigator Leadership Summit met to examine cost data relevant to assessing the economic impact of patient navigation and to propose common cost metrics. RESULTS: Recognizing that resources available for data collection, management, and analysis vary, 5 categories of core and optional cost measures were identified related to patient navigator programs, including program costs, human capital costs, direct medical costs, direct non-medical costs, and indirect costs. CONCLUSIONS: Information demonstrating economic as well as clinical value is necessary to make decisions about sustainability of patient navigation programs. Adoption of these common cost metrics are recommended to promote understanding of the economic impact of patient navigation and comparability across diverse patient navigation programs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。